Frost & Sullivan's Emerging Technologies in Diagnostic Imaging Targets International Markets

Heart disease costs the U.S. healthcare system over $120 billion annually, and 954,000 Americans lose their lives to the devastating ailment. Innovative new products in diagnostic imaging are giving patients a better chance of survival by providing the means for early detection of heart disease and other life-threatening conditions. Moreover, the financial burden placed on healthcare systems is reduced. As more physicians use early detection methods, time, money, and lives are saved through preventative and proactive procedures.

Emerging Technologies, Trends, and Markets in Diagnostic Imaging, strategic research by Frost & Sullivan , maintains a global perspective on six wide-spread diseases facing the world today -- brain tumors, breast cancer, coronary artery disease, epilepsy, skin cancer, and stroke and what new technologies are being used to detect them including: ultrasound contrast agents, magnetoencephalography (MEG), digital holography, electron beam tomography (EBT), digital mammography, computer-aided mammography (CAM), scintimammography, and optical coherence tomography (OCT).

With over 120 charts, Emerging Technologies, Trends, and Markets in Diagnostic Imaging displays incidence rates for the above mentioned diseases in over eighteen countries on five continents. By profiling the individual drivers, restraints, market penetration rates, and potential market size for each product, in each geographic region, competitors can make informed judgments on where markets are going and the most appropriate strategies to gain effective entry.

Current and future technological trends are discussed in these product and regional markets including the results and potential of digitization, emerging methods of image display, and the impact of international medical communication and consultation.

Countries spotlighted in this study include: Canada, the United States, Austria, Finland, France, Germany, Netherlands, Sweden, the United Kingdom, Australia, China, India, Japan, South Korea, Taiwan, Argentina, Brazil, Chile, and Columbia.

Frost & Sullivan is an international marketing consulting company that monitors the medical industry for market trends, market measurements, and strategies.